Plus: A $3 million prize for scientists working with the Large Hadron Collider, why we’re one step closer to a holodeck and ...

Sachin Talwalkar highlights the urgent need for healthcare brands to combat misinformation by building trust through transparent, expert-backed, and more.

Genomics Market Liquid Biopsy Liquid biopsy is a non-invasive method for detecting cancer by analyzing blood samples for genetic mutations ...

Me’s debacle should be a major wake-up call, reminding policymakers and all of us of the risks of giving access to our ...

Me has filed for bankruptcy as is seeking buyers. Here's what could happen to the company's DNA database, one of the largest ...

Me's bankruptcy heightens the debate on genetic data protection. The court will choose between competing plans for overseeing ...

pointing to a host of risks: Genetic data can be used to further discrimination, enable financial fraud, and develop biological weapons, they say. 23andMe has said it will continue operating until ...

The 23andMe collapse reveals deep flaws in how companies treat personal data—not as a sacred trust, but as a disposable asset ...

Moshenberg, the attorney for Kilmar Abrego Garcia, a Maryland resident illegally deported to El Salvador, said on Friday ...

Welcome to Money, Sky News' consumer and financial news hub. Today: house asking prices have reached a record high; what it's ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping job losses. The company that made its name by providing saliva ...